Publication | Open Access

Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Local TherapyOncologyAcquired ResistanceMedicinePathologyTreatment StrategyBronchial NeoplasmCancer TreatmentPharmacologyRadiation OncologyLung Cancer